| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
AU:VFY
Vitrafy Life Sciences Ltd.
|
Oct 29, 2026 | BUY |
Strong Buy
+117.0% avg upside
2 analysts
|
$4.85
113.74% Upside
|
+3.1% | Β· |
|
AU:IDX
Integral Diagnostics Ltd.
|
Oct 29, 2026 | BUY |
Strong Buy
+63.0% avg upside
12 analysts
|
$2.70
53.03% Upside
|
-1.4% | Β· |
|
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
|
Oct 27, 2026 | BUY |
Strong Buy
+146.1% avg upside
2 analysts
|
$0.30
130.70% Upside
|
-3.6% | Β· |
|
AU:LDX
Lumos Diagnostics Holdings Ltd.
|
Oct 27, 2026 | BUY |
Buy
+525.0% avg upside
2 analysts
|
$0.20
233.36% Upside
|
+23.7% | Β· |
|
AU:AYA
Artrya Limited
|
Oct 26, 2026 | BUY |
Strong Buy
+87.1% avg upside
3 analysts
|
$4.30
55.21% Upside
|
+33.9% | Β· |
|
AU:BIO
Biome Australia Ltd
|
Oct 26, 2026 | BUY |
Strong Buy
+108.4% avg upside
1 analyst
|
$0.75
108.42% Upside
|
-4.1% | Β· |
|
AU:EMV
EMvision Medical Devices Ltd.
|
Oct 26, 2026 | BUY |
Strong Buy
+109.7% avg upside
1 analyst
|
$3.15
109.73% Upside
|
-2.9% | Β· |
|
AU:AHC
Austco Healthcare Limited
|
Oct 20, 2026 | BUY |
Strong Buy
+78.6% avg upside
1 analyst
|
$0.50
78.60% Upside
|
-1.9% | Β· |
|
AU:MVP
Medical Developments International Limited
|
Oct 15, 2026 | BUY |
Strong Buy
+173.9% avg upside
1 analyst
|
$1.00
173.94% Upside
|
+1.2% | Β· |
|
AU:EBR
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
|
Oct 13, 2026 | BUY |
Strong Buy
+979.5% avg upside
3 analysts
|
$0.20
53.90% Upside
|
-12.9% | Β· |
|
AU:MVF
Monash IVF Group Ltd
|
Aug 31, 2026 | HOLD |
Strong Buy
+35.5% avg upside
7 analysts
|
$0.75
4.12% Upside
|
-0.3% | Β· |
|
AU:TRJ
Trajan Group Holdings Ltd
|
Aug 28, 2026 | BUY |
Strong Buy
+233.3% avg upside
3 analysts
|
$0.50
99.92% Upside
|
+29.3% | Β· |
|
AU:IPD
Impedimed Limited
|
Aug 27, 2026 | BUY |
Strong Buy
+2150.0% avg upside
5 analysts
|
$0.01
150.10% Upside
|
-40.0% | Β· |
|
AU:SHL
Sonic Healthcare Limited
|
Aug 20, 2026 | BUY |
Hold
+23.5% avg upside
12 analysts
|
$27.50
40.60% Upside
|
-1.7% | Β· |
|
AU:AT1
Atomo Diagnostics Ltd.
|
Oct 31, 2022 | HOLD |
Hold
1 analyst
|
β | -62.7% | Β· |
|
AU:RCL
ReadCloud Ltd.
|
Oct 31, 2022 | HOLD |
Hold
1 analyst
|
β | -61.9% | Β· |
|
AU:NAN
Nanosonics Limited
|
Oct 31, 2022 | HOLD |
Hold
+56.7% avg upside
7 analysts
|
β | -9.6% | Β· |
|
AU:MYX
Mayne Pharma Group
|
Oct 31, 2022 | HOLD |
Hold
+52.8% avg upside
3 analysts
|
β | -26.8% | Β· |
|
AU:AMS
Atomos
|
Oct 31, 2022 | HOLD |
Hold
1 analyst
|
β | -38.1% | Β· |
|
AU:MAP
Microba Life Sciences Limited
|
Oct 31, 2022 | HOLD |
Hold
+45.0% avg upside
2 analysts
|
β | +25.5% | Β· |
|
AU:PCK
PainChek Ltd
|
Oct 31, 2022 | HOLD |
Hold
1 analyst
|
β | +40.0% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.